Using BALB/c mice because they contain more of these two unconventional subtypes of T-cells26,30,31, and peripheral blood material from BCR-ABL+ CML patients, we have demonstrated that dasatinib can influence both cell subtypes at functional and/or numerical level(s). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.